We live in the age of -omics. We have genomics to study complete sets of DNA. We have proteomics focused on all the proteins ...

As digital transformation continues to reshape the life sciences industry, the ability to leverage quality data alongside advanced technologies will be essential.

The burgeoning field of exposomics aims to precisely measure the combined impact of environmental and biological factors on human life. After coming together at Cold Spring Harbor Laboratory’s Banbury ...

A new cancer treatment discovered by the University of California San Diego Sanford Stem Cell Institute (SSCI) and developed ...

The $91 million expansion near I-77 and Farrow Road has already surpassed the hiring expectations of 100 jobs, the ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

STOCKHOLM--Swedish buyout group EQT and French pharmaceutical major Sanofi co-led a $135 million series B financing round in Spanish biotech company SpliceBio. EQT co-led the funding round with Sanofi ...

The main findings of the study, published in Cell, were: The researchers identified 851 distinct N-acyl lipids across various ...

Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin ...

Some key biotechnology acquisitions this year included Vertex Pharmaceuticals purchasing Alpine Immune Science and Novartis acquiring MorphySys for $5 and $2.9 billion USD, respectively.

With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...